Back to search
FDAFDA · Food and drugs·Recall number D-1041-2016

VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619

Published June 29, 2016 · Recall initiated: May 11, 2016

Summary

FDA records drug Class II recall D-1041-2016, published June 29, 2016 and initiated May 11, 2016. Recalling firm: Profarma Distributors LLC; Status: Terminated; Reported quantity: 163 boxes (978 tablets); Lot: Lot # UPE187; Exp. 08/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Profarma Distributors LLC
Distributor
Nationwide
UPC
7501109900619
Lot
Lot # UPE187; Exp. 08/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619 recalled?

Yes. FDA published recall D-1041-2016 on June 29, 2016. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 7501109900619.